Wen-Yu Chang Selected Research

Wen-Yu Chang Research Topics

Disease

28	Chronic Hepatitis C 04/2015 - 01/2002
23	Infections 01/2021 - 01/2002
9	Fibrosis (Cirrhosis) 02/2012 - 03/2002
6	Viremia 01/2021 - 01/2002
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2011 - 03/2002
4	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 04/2005
4	Chronic Hepatitis B 12/2007 - 02/2006
4	Coinfection 01/2006 - 10/2004
2	Atopic Dermatitis (Atopic Eczema) 04/2024 - 02/2010
2	Neoplasms (Cancer) 01/2017 - 02/2002
2	Hepatitis C 07/2008 - 02/2006
2	Disease Susceptibility (Diathesis) 09/2006 - 06/2003
1	Inflammation (Inflammations) 09/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2021
1	Dermatitis 09/2021
1	Hyperplasia 09/2021
1	Vitiligo 02/2010
1	Insulin Resistance 04/2009
1	Acute Generalized Exanthematous Pustulosis 12/2008
1	Hypercholesterolemia 07/2008
1	End Stage Liver Disease 12/2007
1	Hepatitis 06/2007
1	Body Weight (Weight, Body) 02/2006
1	Thalassemia 01/2006
1	Massive Hepatic Necrosis 09/2005
1	Necrosis 07/2005
1	Virus Diseases (Viral Diseases) 07/2003
1	Pulmonary Embolism 11/2002
1	Hemorrhage 11/2002
1	Melena 11/2002
1	Varicose Veins (Varicose Vein) 11/2002
1	Hepatitis B 06/2002
1	Bacterial Infections (Bacterial Infection) 03/2002
1	Chronic Hepatitis (Chronic Active Hepatitis) 02/2002

Drug/Important Bio-Agent (IBA)

16	Ribavirin (Virazole)FDA LinkGeneric 04/2015 - 10/2004
14	RNA (Ribonucleic Acid)IBA 02/2012 - 01/2002
13	Interferon-alpha (Interferon Alfa)IBA 12/2006 - 01/2002
10	InterferonsIBA 03/2010 - 07/2003
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 06/2002
3	DNA (Deoxyribonucleic Acid)IBA 12/2007 - 01/2002
3	Alanine Transaminase (SGPT)IBA 12/2006 - 01/2002
2	Lamivudine (Epivir)FDA Link 12/2007 - 08/2007
2	Interferon-gamma (Interferon, gamma)IBA 09/2006 - 08/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006 - 06/2003
1	baricitinibIBA 04/2024
1	dupilumabIBA 04/2024
1	Interleukin-23 (Interleukin 23)IBA 09/2021
1	Therapeutic UsesIBA 09/2021
1	Capsaicin (Zostrix)FDA Link 09/2021
1	CytokinesIBA 09/2021
1	Imiquimod (Aldara)FDA LinkGeneric 09/2021
1	PhosphopeptidesIBA 01/2017
1	CationsIBA 01/2017
1	titanium dioxide (Titania)FDA Link 01/2017
1	Antinuclear AntibodiesIBA 02/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2011
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2010
1	Ointments (Pastes)IBA 02/2010
1	SteroidsIBA 02/2010
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 03/2009
1	Acarbose FDA LinkGeneric 12/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2008
1	Glucose (Dextrose)FDA LinkGeneric 08/2008
1	CholesterolIBA 07/2008
1	LipidsIBA 07/2008
1	Triglycerides (Triacylglycerol)IBA 07/2008
1	Hepatitis B e AntigensIBA 12/2007
1	adefovir dipivoxil (Hepsera)FDA Link 08/2007
1	Hepatitis C AntibodiesIBA 06/2007
1	Surface Antigens (Surface Antigen)IBA 06/2007
1	IronIBA 01/2006
1	triplex DNA (H-DNA)IBA 10/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2003
1	Transaminases (Aminotransferases)IBA 06/2003
1	Sclerosing Solutions (Sclerosing Agents)IBA 11/2002
1	AntigensIBA 06/2002
1	C-Reactive ProteinIBA 03/2002
1	Indicators and Reagents (Reagents)IBA 03/2002

Therapy/Procedure

18	Therapeutics 02/2012 - 01/2002
2	Renal Dialysis (Hemodialysis) 08/2005 - 02/2002
1	Phototherapy (Light Therapy) 02/2010
1	Duration of Therapy 06/2008
1	Ligation 11/2002
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 11/2002
1	Radiotherapy 02/2002
1	Blood Transfusion (Blood Transfusions) 01/2002